HIGHLIGHTS
- who: CONSENSUS REPORT and collaborators from the Department of Microbiology, Immunology and, Paris Translational Research Center for Organ, Necker, France, Department of Nephrology, Radboud University Medical have published the article: Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation, in the Journal: (JOURNAL) of December/31,/2019
- what: This article proposes the rationale for surrogate endpoints for CMA, for novel kidney transplantation therapies; the paper also provides background data that illustrate the relationship between surrogate and primary endpoints, to support full marketing authorization. Lastly, there are relevant differences in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.